About us
Join our global network
Leadership
Life at Baker Tilly
Press room
Industries
Services
Advisory
Consulting
Transactions
Digital
Risk advisory and ESG
Audit and assurance
ESG regulatory reporting
Legal
Commercial law
Corporate law and M&A
Data protection and IP law
Employment law
Litigation and dispute resolution
Real estate law
Recovery and restructuring
Tax
Corporate tax
International tax
Transfer pricing
Indirect tax
Global mobility
Private clients
Global Tax Solutions
Insights
Case studies
Regions
Contact
Close
Loading...
Close
About us
About us
Join our global network
Leadership
Life at Baker Tilly
Press room
Industries
Services
Services
Advisory
Advisory
Consulting
Transactions
Digital
Risk advisory and ESG
Audit and assurance
Audit and assurance
ESG regulatory reporting
Legal
Legal
Commercial law
Corporate law and M&A
Data protection and IP law
Employment law
Litigation and dispute resolution
Real estate law
Recovery and restructuring
Tax
Tax
Corporate tax
International tax
Transfer pricing
Indirect tax
Global mobility
Private clients
Global Tax Solutions
Insights
Insights
Case studies
Regions
Contact
Insights
Service
Advisory
Audit and assurance
Legal
Tax
Industry
Agribusiness
Automotive and transport
Energy, natural resources and industrials
Education
Financial services
Life sciences and healthcare
Manufacturing and distribution
Not for profit
Professional services
Public sector
Real estate
Retail, consumer and hospitality
Technology, software and media
Tourism
Sports
Region
Global
Africa
Asia Pacific
Caribbean
Europe
Latin America
Middle East
North America
Category
Article
Podcast
Report / Guide
Reset
Article
International tax
Global
Preparing for BEPS 2.0: are you ready?
Since last year's announcement on a 15% minimum corporate tax rate, multinationals are moving to understand what various changes might mean.
Chris Danes - UK
16 November, 2022
Article
Corporate tax
Europe
BEFIT could be better for business but road to reform is long
BEFIT could simplify corporate tax for European multinationals, easing scalability, yet transfer pricing complexities persist.
16 November, 2022
Inbox insights from Baker Tilly
Sign up to our regular newsletter and receive all the latest insights. Straight to your inbox.
Article
Advisory
Europe
UK's uncertain economy puts spotlight on alternative finance
Rising costs of finance and ongoing economic uncertainty in the United Kingdom are underscoring the advantages of alternative lenders.
Gregory Taylor - UK
10 November, 2022
Article
Europe
Investment Zones a welcome boost for UK's countryside counties
A strong response from regional areas suggests the UK's new Investment Zone initiative has been well-received.
7 November, 2022
Article
International tax
Global
Global minimum tax reforms threatened by cross-border complexities
Baker Tilly's Ines Paucksch warns companies could face complex and varying start dates if countries manage to pass global minimum tax reforms into law.
6 October, 2022
Article
Life sciences and healthcare
Europe
Compulsory licensing: should vaccines be public property?
European leaders are facing industry backlash over potential compulsory licensing of vaccines to hedge against the risk of future pandemics.
16 September, 2022
Article
Retail, consumer and hospitality
Europe
Shelf awareness: grocery shortages explained
Food inflation and grocery shortages are widespread but the problem is deeper than ingredient shortages and supply bottlenecks.
29 August, 2022
Article
Tourism
Automotive and transport
Global
Are the world's airports and airlines broken?
It was the moment airports and airlines waited more than two years for - why did the business of travel buckle when tourists returned?
17 August, 2022
Article
Advisory
Europe
Man overboard: what will gender quotas mean for EU company directors?
The EU’s new gender diversity mandates are a major milestone for equality but experts warn there is still a long way to go for genuine balance.
12 August, 2022
Article
Advisory
Life sciences and healthcare
Europe
Skills shortage strains UK life science sector
Ambitions are soaring for the UK’s pharma. life science and biotech industry on the back of record investment but can it be sustained?
Yogan Patel - UK
11 July, 2022
Previous
1
2
3
4
5
6
7
8
9
Next
People on the ground.
Wherever the opportunity lands.
International enquiries
Multi-jurisdiction and cross-border services
Contact the global team
National enquiries
Domestic expertise, local insights
Find your local firm